- Home
- LLYVK vs ICLR Comparison
LLYVK vs ICLR Comparison
Compare LLYVK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LLYVK | ICLR |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.3B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | LLYVK | ICLR |
|---|---|---|
| Price | $101.03 | $136.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | 301.2K | ★ 995.1K |
| Earning Date | 02-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.52 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $72.29 | $66.57 |
| 52 Week High | $102.14 | $211.00 |
Technical Indicators
Market Signals| Indicator | LLYVK | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 62.17 | 69.39 |
| Support Level | $94.71 | $99.11 |
| Resistance Level | $101.64 | $193.87 |
| Average True Range (ATR) | 2.82 | 6.67 |
| MACD | 0.18 | 1.97 |
| Stochastic Oscillator | 91.61 | 88.02 |
Price Performance
Historical ComparisonAbout LLYVK Liberty Media Corporation
Liberty Live Holdings Inc focuses on live entertainment investments. The company maintains a substantial ownership position in Live Nation Entertainment, the primary international promoter of concerts, events, and ticketing through platforms like Ticketmaster, alongside sponsorship and hospitality services via QuintEvents.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.